Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5 ‐Lipoxygenase Activating Protein Inhibitor

Clinical and Translational Science, EarlyView.

Source: Clinical and Translational Science - March 8, 2018 Category: Biomedical Science Source Type: research